首页> 美国卫生研究院文献>Diabetes Care >Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

【2h】

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

机译：坎地沙坦对心衰患者的死亡率和发病率降低（CHARM）程序进行评估时预测坎地沙坦对慢性心力衰竭患者糖尿病的发展趋势

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVEThe purpose of this study was to identify predictors of incident diabetes during follow-up of nondiabetic patients with chronic heart failure (CHF) in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program.

机译：目的本研究的目的是在Candesartan的心衰减少死亡率和发病率评估（CHARM）计划中确定非糖尿病慢性心力衰竭（CHF）患者随访期间发生糖尿病的预测因素。

著录项

期刊名称 Diabetes Care
作者
David Preiss; Sofia Zetterstrand; John J.V. McMurray; Jan Östergren; Eric L. Michelson; Christopher B. Granger; Salim Yusuf; Karl Swedberg; Marc A. Pfeffer; Hertzel C. Gerstein; Naveed Sattar;
展开▼
作者单位

展开▼
年(卷),期 2009(32),5
年度 2009
页码 915–920
总页数 6
原文格式 PDF
正文语种
中图分类护理学;
关键词

相似文献

外文文献
中文文献
专利

1. Predictors of development of diabetes in patients with chronic heart failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) program. [J] . Preiss D, Zetterstrand S, McMurray JJ, Diabetes care . 2009,第5期

机译：Candesartan在“降低死亡率和发病率（CHARM）的心力衰竭评估”中对慢性心力衰竭患者糖尿病的发展进行了预测。
2. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. [J] . Pocock SJ, McMurray JJ, Dobson J, European Heart Journal: The Journal of the European Society of Cardiology . 2008,第21期

机译：坎地沙坦治疗心力衰竭的慢性心力衰竭患者的体重减轻和死亡风险：降低死亡率和发病率（CHARM）计划的评估。
3. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme [J] . Stuart J. Pocock1* John J.V. McMurray2 Joanna Dobson1 Salim Yusuf3 Christopher B. Granger4 Eric L. Michelson5 Jan Östergren6 Marc A. Pfeffer7 Scott D. Solomon7 Stefan D. Anker8 and Karl B. Swedberg9 on behalf of the CHARM Investigators European Heart Journal . 2008,第21期

机译：坎地沙坦治疗慢性心力衰竭患者的体重减轻和死亡风险：降低死亡率和发病率（CHARM）计划的评估
4. Predictive Models for Risk Assessment of Worsening Events in Chronic Heart Failure Patients [C] . Maria Carmela Groccia, Danilo Lofaro, Rosita Guido, Computing in Cardiology Conference . 2018

机译：慢性心力衰竭患者恶化事件风险评估的预测模型
5. Factors associated with adherence in heart failure. A secondary analysis of a large clinical trial: Candesartan in Heart failure -Assessment of Reduction in Mortality and Morbidity (CHARM) [D] . Granger, Bradi B. 2004

机译：与心力衰竭依从性相关的因素。大型临床试验的次要分析：坎地沙坦治疗心力衰竭-死亡率和发病率降低的评估（CHARM）
6. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program [O] . Larry A. Allen, G. Michael Felker, Stuart Pocock, -1

机译：慢性心力衰竭患者的肝功能异常和预后：Candesartan的心力衰竭数据：死亡率和发病率降低计划的评估
7. Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program [O] . Preiss, David, Zetterstrand, Sofia, McMurray, John J.V., 2009

机译：Candesartan评估心衰患者死亡率和发病率（CHARM）计划减少中慢性心力衰竭患者糖尿病的发展预测因素

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

摘要

著录项

相似文献

相关主题

期刊订阅